Evaxion A EVAX
NASDAQ EVAX
$3.17 -0.11 (-3.35%)
As of: Oct 1, 2026 · 1:34 PM EDT

Evaxion A (EVAX) Long-Term Debt Repayments (2022)

Updated

Evaxion A's Long-Term Debt Repayments was -$399,000 in FY2025, compared with -$805,000 in FY2024.

Analysis

Evaxion A (EVAX) Long-Term Debt Repayments (2022) Analysis & Trends

From FY2021 onward, Evaxion A has reported Long-Term Debt Repayments for 5 years.

  • Annual Long-Term Debt Repayments has moved between -$805,000 (FY2024) and -$63,000 (FY2021) over five years.
  • Per Business Quant data, Long-Term Debt Repayments in earlier years was -$805,000 in FY2024, -$371,000 in FY2023, -$119,000 in FY2022 and -$63,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -30,000.00
Mar 31, 2022 -30,000.00
API Access

Evaxion A Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EVAX&period=max&api_key=YOUR_API_KEY